Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Calais

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot studyG Calais, E Dorval, P Louisot, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implicationsC Berger, A de Muret, P Garaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[Effect radiotherapy on postoperative staging and residual tumor cell density in rectal cancers]C Berger, A de Muret, P Garaud, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.
Clinical and Translational Radiation Oncology|January 1, 2024
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysisC Yuste, V Passerat, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 7, 2019
[Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study]N Scher, G Janoray, F-G Riet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapyC Linassier, C Barin, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2000
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyJ C Horiot, F Lipinski, S Schraub, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2025
Radiation-associated angiosarcoma of the breast: consider chemotherapyA Michot, A Giraud, M Karanian, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
International Journal of Radiation Oncology, Biology, Physics|July 1, 1997
Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot studyG Calais, E Dorval, P Louisot, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1997
Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implicationsC Berger, A de Muret, P Garaud, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 1, 1997
[Effect radiotherapy on postoperative staging and residual tumor cell density in rectal cancers]C Berger, A de Muret, P Garaud, et al.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.
Clinical and Translational Radiation Oncology|January 1, 2024
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysisC Yuste, V Passerat, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 7, 2019
[Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study]N Scher, G Janoray, F-G Riet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapyC Linassier, C Barin, G Calais, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2005
[Propositions for the selection and the delineation of peritumoral microscopic disease volumes in oral cavity and oropharyngeal cancers (lymph nodes excluded)]M Lapeyre, P Henrot, M Alfonsi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2000
Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyJ C Horiot, F Lipinski, S Schraub, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2025
Radiation-associated angiosarcoma of the breast: consider chemotherapyA Michot, A Giraud, M Karanian, et al.
Pageof 12